Third Time Is The Charm For ReGen’s Knee Repair Collagen Scaffold
This article was originally published in The Gray Sheet
Executive Summary
ReGen Biologics plans a February U.S. launch of its Menaflex collagen knee cartilage repair product at the 2009 American Academy of Orthopedic Surgeons meeting in Las Vegas now that FDA has signed off on the product after several years of resistance
You may also be interested in...
Do-Over? FDA Orders Look-Back At Knee Device 510(k) Review Process
In a sign of the intense scrutiny CDRH is facing under the new administration, FDA is taking the rare step of performing an internal review of its decision process for a recently 510(k)-cleared device. The inquiry could potentially lead to a "reconsideration" of the clearance, the agency says
Do-Over? FDA Orders Look-Back At Knee Device 510(k) Review Process
In a sign of the intense scrutiny CDRH is facing under the new administration, FDA is taking the rare step of performing an internal review of its decision process for a recently 510(k)-cleared device. The inquiry could potentially lead to a "reconsideration" of the clearance, the agency says
Device Center Discord: 510(k) Review Process Is Flash Point At CDRH
Details trickling into the public sphere about CDRH's device review process reveal heightened tension between reviewers and management over the proper response to a 510(k) submission